Jonathan Weiss, MD
MOHS-Micrographic Surgery · Boston, MANPI 1225327844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,500 of the $3,392 with a category attached, or 73.7%. Dermira, Inc. accounts for 73.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $2,547 and has fallen 85.7% since, to $365 in 2025.
Across 18 payments — averaging $188.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermira, Inc.$3K
- Abbott$175
- Johnson & Johnson$169
- Arcutis Biotherapeutics, Inc.$105
- Sanofi$98
- Sanofi-aventis U.S. LLC$85
- plus $260 from 8 others
Across 1 payment — averaging $4355.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$4K
What the payments were for
- Consulting fees$2,50074%
- Food & beverage$80724%
- Education$853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermira, Inc. | 1 | $2,500 |
| Abbott | 1 | $175 |
| Johnson & Johnson | 4 | $169 |
| Arcutis Biotherapeutics, Inc. | 1 | $105 |
| Sanofi | 1 | $98 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| UCB, Inc. | 1 | $83 |
| Galderma Laboratories, L.p. | 2 | $40 |
| LEO Pharma Inc. | 1 | $31 |
| Incyte Corporation | 1 | $27 |
| GSK | 1 | $23 |
| Almirall LLC | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QBREXZA$2,500
- ENSITE PRECISION$175
- ZORYVE$105
How this compares
$3,392 in reported general payments places this provider in the 70th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 31 | $183 |
| Ketoconazole | 13 | $159 |
| Mupirocin | 16 | $105 |
| Triamcinolone Acetonide | 12 | $74 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Boston
- Sameer GuptaBoston$11K
- Benjamin SolkyBoston$7K
- Paul MasseyBoston$1K
- Anna SutherlandBoston$657
- Katayun AdhamiBoston$560
- Ramone WilliamsBoston$200
- Nina RanBoston$121
- Patricia RicheyBoston$47
- Chrysalyne SchmultsJamaica Plain$58K
- Suzanne OlbrichtBurlington$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.